Oral contraceptives ‘may cut diabetes risk in PCOS’
Observational data suggest a need for randomised controlled trials to test such an intervention, researchers say
Combined oral contraceptive pills may reduce the risk of type 2 diabetes and prediabetes by more than a quarter in women with polycystic ovary syndrome, a database study suggests.
The cohort study is also the largest to confirm that polycystic ovary syndrome (PCOS) is associated with double the risk of developing diabetes.
